English

Q Therapeutics, Inc.

EDGAR

Quarterly report (10-Q) · filed 2015-11-13

42 filing records in this dataset, filed from 2006-10-12 to 2015-11-13. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

10.4 thousand USD

2014 Q4 · USD

Exact inputs and evidence

Revenue: 680264 USD Source
Revenue: 669856 USD Source

Operating margin

-8,887.01%

2014 Q4 · %

Exact inputs and evidence

Operating Income: -3380202 USD Source
Operating Income: -2455242 USD Source
Revenue: 680264 USD Source
Revenue: 669856 USD Source

Operating cash flow

-381 thousand USD

2014 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -1458653 USD Source
Operating Cash Flow: -1077494 USD Source

Free cash flow

-384 thousand USD

2014 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -1458653 USD Source
Operating Cash Flow: -1077494 USD Source
Capital Expenditure: 8234 USD Source
Capital Expenditure: 5615 USD Source

Cash and cash equivalents: 23.2 thousand USD 2015-09-30 Source
Exact value

23218 USD
Long-term debt including current maturities: Not available
Shares outstanding: 30.8 million shares 2015-09-30 Source
Exact value

30826549 shares

Reported share-count change

1.41% · 429 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

30397460 shares · 2014-09-30· Source
30826549 shares · 2015-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-3.4 million USD

2014-10-01 – 2015-09-30

Exact inputs and evidence

Net income: -3350701 USD · 2014-01-01 – 2014-12-31 Source
Net income: -2524681 USD · 2014-01-01 – 2014-09-30 Source
Net income: -763087 USD · 2015-01-01 – 2015-03-31 Source
Net income: -806680 USD · 2015-04-01 – 2015-06-30 Source
Net income: -1003445 USD · 2015-07-01 – 2015-09-30 Source

Operating cash flow

-1.45 million USD

2014-10-01 – 2015-09-30

Exact inputs and evidence

Operating cash flow: -1458653 USD · 2014-01-01 – 2014-12-31 Source
Operating cash flow: -1077494 USD · 2014-01-01 – 2014-09-30 Source
Operating cash flow: -373917 USD · 2015-01-01 – 2015-03-31 Source
Operating cash flow: -833325 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: -373917 USD · 2015-01-01 – 2015-03-31 Source
Operating cash flow: -1071536 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -833325 USD · 2015-01-01 – 2015-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2015-11-13.

Financial data available through: 2014-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2014-12-31
Operating income: 7 of 11 periods available· newest 2014-12-31
Net income: 11 of 11 periods available· newest 2014-12-31
Operating cash flow: 10 of 11 periods available· newest 2014-12-31
Capital expenditure: 4 of 11 periods available· newest 2014-12-31
Total assets: 8 of 11 periods available· newest 2014-12-31
Total liabilities: 5 of 11 periods available· newest 2014-12-31
Current assets: 5 of 11 periods available· newest 2014-12-31
Current liabilities: 7 of 11 periods available· newest 2014-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2014-12-31
long term debt: No compatible figures in this window
Shares outstanding: 5 of 11 periods available· newest 2014-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+2,498.9%

Prior period

USD 26,175

2013-01-01 – 2013-12-31
Current period

USD 680,264

2014-01-01 – 2014-12-31

Exact inputs and evidence

680264 − 26175 = 654089 USD

26175 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
680264 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Q Therapeutics, Inc. · 2014-12-31 Q Therapeutics, Inc. (edgar:1366541) Year-over-year change in Revenue: 654089 USD Concept: fundies:Revenue Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 680264 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312515114403/qhoi-20141231.xml#60079 Filing: 000119312515114403 Input fundies:Revenue: 26175 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312515114403/qhoi-20141231.xml#62487 Filing: 000119312515114403
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 38,391

Prior period

−USD 3.39 million

2013-01-01 – 2013-12-31
Current period

−USD 3.35 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

-3350701 − -3389092 = 38391 USD

-3389092 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
-3350701 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Q Therapeutics, Inc. · 2014-12-31 Q Therapeutics, Inc. (edgar:1366541) Year-over-year change in Net income: 38391 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -3350701 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312515114403/qhoi-20141231.xml#61896 Filing: 000119312515114403 Input fundies:NetIncome: -3389092 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312515114403/qhoi-20141231.xml#64258 Filing: 000119312515114403
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 580,780

Prior period

−USD 877,873

2013-01-01 – 2013-12-31
Current period

−USD 1.46 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

-1458653 − -877873 = -580780 USD

-877873 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
-1458653 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Q Therapeutics, Inc. · 2014-12-31 Q Therapeutics, Inc. (edgar:1366541) Year-over-year change in Operating cash flow: -580780 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1458653 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312515114403/qhoi-20141231.xml#71538 Filing: 000119312515114403 Input fundies:OperatingCashFlow: -877873 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312515114403/qhoi-20141231.xml#73766 Filing: 000119312515114403
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-65.4%

Prior period

USD 23,802

2013-01-01 – 2013-12-31
Current period

USD 8,234

2014-01-01 – 2014-12-31

Exact inputs and evidence

8234 − 23802 = -15568 USD

23802 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
8234 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Q Therapeutics, Inc. · 2014-12-31 Q Therapeutics, Inc. (edgar:1366541) Year-over-year change in Capital expenditure: -15568 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 8234 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312515114403/qhoi-20141231.xml#71711 Filing: 000119312515114403 Input fundies:CapitalExpenditure: 23802 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312515114403/qhoi-20141231.xml#73938 Filing: 000119312515114403
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2014 2014-01-01 – 2014-12-31

Revenue USD 680,264 100% of revenue
Cost of revenue USD 800 0.1% of revenue
Operating expenses USD 4.06 million 597% of revenue
Operating income −USD 3.38 million −497% of revenue
Tax, interest and other Derived −USD 29,501 −4.3% of revenue
Net income −USD 3.35 million −493% of revenue

Cash

Operating cash flow −USD 1.46 million −214% of revenue
Capital expenditure USD 8,234 1.2% of revenue
Free cash flow Derived −USD 1.47 million −216% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2010 Operating loss: operating costs were 294% of revenue.
2011 Not shown: operating income or net income is not reported.
2011 Operating loss: operating costs were 1,152% of revenue.
2012 Operating loss: operating costs were 731% of revenue.
2013 Operating loss: operating costs were 12,291% of revenue.
2014 Operating loss: operating costs were 597% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2010 2010-01-01 – 2010-12-31	452241	1328230 Derived	-875989	-11139 Derived	-864850	Unavailable	Source 2010-01-01 – 2010-12-31: 452241 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -875989 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -864850 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -811794 USD Inspect Operating Cash Flow Open source
2011 2010-03-01 – 2011-02-28	0	Unavailable	Unavailable	Unavailable	-18200	Unavailable	Source 2010-03-01 – 2011-02-28: 0 USD Inspect Revenue Open source 2010-03-01 – 2011-02-28: -18200 USD Inspect Net Income Open source 2010-03-01 – 2011-02-28: -8975 USD Inspect Operating Cash Flow Open source
2011 2011-01-01 – 2011-12-31	174573	2011846 Derived	-1837273	762065 Derived	-2599338	-1670997 Derived	Source 2011-01-01 – 2011-12-31: 174573 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -1837273 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -2599338 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -1665370 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 5627 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	485031	3547409 Derived	-3062378	-4538 Derived	-3057840	-2124112 Derived	Source 2012-01-01 – 2012-12-31: 485031 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -3062378 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -3057840 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -2121749 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 2363 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	26175	3217045 Derived	-3190870	198222 Derived	-3389092	-901675 Derived	Source 2013-01-01 – 2013-12-31: 26175 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -3190870 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -3389092 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -877873 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 23802 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	680264	4060466 Derived	-3380202	-29501 Derived	-3350701	-1466887 Derived	Source 2014-01-01 – 2014-12-31: 680264 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -3380202 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -3350701 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -1458653 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 8234 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 680.3K 2014

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-06-02	Revenue	0	Revenue: 0 Open source
20072007-05-31	Revenue	0	Revenue: 0 Open source
20102010-12-31	Revenue	452241	Revenue: 452241 Open source
20112011-02-28	Revenue	0	Revenue: 0 Open source
20112011-12-31	Revenue	174573	Revenue: 174573 Open source
20122012-12-31	Revenue	485031	Revenue: 485031 Open source
20132013-12-31	Revenue	26175	Revenue: 26175 Open source
20142014-12-31	Revenue	680264	Revenue: 680264 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

2,498.9% 2014

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20062006-06-02	Year over year	No prior comparable period	Revenue: 0 Open source
20072007-05-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20102010-12-31	Year over year	No prior comparable period	Revenue: 452241 Open source
20112011-02-28	Year over year	No prior comparable period	Revenue: 0 Open source
20112011-12-31	Year over year	-61.4%	Revenue: 174573 Open source Revenue: 452241 Open source
20122012-12-31	Year over year	177.8%	Revenue: 485031 Open source Revenue: 174573 Open source
20132013-12-31	Year over year	-94.6%	Revenue: 26175 Open source Revenue: 485031 Open source
20142014-12-31	Year over year	2,498.9%	Revenue: 680264 Open source Revenue: 26175 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -496.9% 2014

Net margin -492.6% 2014

Free cash flow margin -215.6% 2014

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2006-06-02	Operating margin	Not reported	Revenue: 0 Open source
2007-05-31	Operating margin	Not reported	Revenue: 0 Open source
20102010-12-31	Operating margin	-193.7%	Operating Income: -875989 Open source Revenue: 452241 Open source
2011-02-28	Operating margin	Not reported	Revenue: 0 Open source
20112011-12-31	Operating margin	-1,052.4%	Operating Income: -1837273 Open source Revenue: 174573 Open source
20122012-12-31	Operating margin	-631.4%	Operating Income: -3062378 Open source Revenue: 485031 Open source
20132013-12-31	Operating margin	-12,190.5%	Operating Income: -3190870 Open source Revenue: 26175 Open source
20142014-12-31	Operating margin	-496.9%	Operating Income: -3380202 Open source Revenue: 680264 Open source
2006-06-02	Net margin	Not reported	Revenue: 0 Open source
20072007-05-31	Net margin	Not reported	Net Income: -100 Open source Revenue: 0 Open source
20102010-12-31	Net margin	-191.2%	Net Income: -864850 Open source Revenue: 452241 Open source
20112011-02-28	Net margin	Not reported	Net Income: -18200 Open source Revenue: 0 Open source
20112011-12-31	Net margin	-1,489%	Net Income: -2599338 Open source Revenue: 174573 Open source
20122012-12-31	Net margin	-630.4%	Net Income: -3057840 Open source Revenue: 485031 Open source
20132013-12-31	Net margin	-12,947.8%	Net Income: -3389092 Open source Revenue: 26175 Open source
20142014-12-31	Net margin	-492.6%	Net Income: -3350701 Open source Revenue: 680264 Open source
20062006-06-02	Free cash flow margin	Not reported	Revenue: 0 Open source
20072007-05-31	Free cash flow margin	Not reported	Revenue: 0 Open source
20102010-12-31	Free cash flow margin	Not reported	Revenue: 452241 Open source Operating Cash Flow: -811794 Open source
20112011-02-28	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -8975 Open source
20112011-12-31	Free cash flow margin	-957.2%	Revenue: 174573 Open source Operating Cash Flow: -1665370 Open source Capital Expenditure: 5627 Open source
20122012-12-31	Free cash flow margin	-437.9%	Revenue: 485031 Open source Operating Cash Flow: -2121749 Open source Capital Expenditure: 2363 Open source
20132013-12-31	Free cash flow margin	-3,444.8%	Revenue: 26175 Open source Operating Cash Flow: -877873 Open source Capital Expenditure: 23802 Open source
20142014-12-31	Free cash flow margin	-215.6%	Revenue: 680264 Open source Operating Cash Flow: -1458653 Open source Capital Expenditure: 8234 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.5M 2014

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-06-02	Operating cash flow	Not reported	No source recorded
20072007-05-31	Operating cash flow	Not reported	No source recorded
20102010-12-31	Operating cash flow	-811794	Operating Cash Flow: -811794 Open source
20112011-02-28	Operating cash flow	-8975	Operating Cash Flow: -8975 Open source
20112011-12-31	Operating cash flow	-1665370	Operating Cash Flow: -1665370 Open source
20122012-12-31	Operating cash flow	-2121749	Operating Cash Flow: -2121749 Open source
20132013-12-31	Operating cash flow	-877873	Operating Cash Flow: -877873 Open source
20142014-12-31	Operating cash flow	-1458653	Operating Cash Flow: -1458653 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1.5M 2014

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-06-02	Free cash flow	Unavailable	No source recorded
20072007-05-31	Free cash flow	Unavailable	No source recorded
20102010-12-31	Free cash flow	Unavailable	Operating Cash Flow: -811794 Open source
20112011-02-28	Free cash flow	Unavailable	Operating Cash Flow: -8975 Open source
20112011-12-31	Free cash flow	-1670997	Operating Cash Flow: -1665370 Open source Capital Expenditure: 5627 Open source
20122012-12-31	Free cash flow	-2124112	Operating Cash Flow: -2121749 Open source Capital Expenditure: 2363 Open source
20132013-12-31	Free cash flow	-901675	Operating Cash Flow: -877873 Open source Capital Expenditure: 23802 Open source
20142014-12-31	Free cash flow	-1466887	Operating Cash Flow: -1458653 Open source Capital Expenditure: 8234 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

139.5% 2014

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20062006-06-02	Liabilities / assets	Not reported	Total Liabilities: 0 Open source Total Assets: 0 Open source
20072007-05-31	Liabilities / assets	266.7%	Total Liabilities: 4000 Open source Total Assets: 1500 Open source
2010-12-31	Liabilities / assets	Not reported	Total Assets: 566686 Open source
20112011-02-28	Liabilities / assets	Not reported	Total Liabilities: 44425 Open source Total Assets: 0 Open source
20112011-12-31	Liabilities / assets	10.4%	Total Liabilities: 293794 Open source Total Assets: 2834751 Open source
2012-12-31	Liabilities / assets	Not reported	Total Assets: 1305932 Open source
2013-12-31	Liabilities / assets	Not reported	Total Assets: 257042 Open source
20142014-12-31	Liabilities / assets	139.5%	Total Liabilities: 1044163 Open source Total Assets: 748311 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.69× 2014

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2006-06-02	Current assets / current liabilities	Not reported	Current Liabilities: 0 Open source
2007-05-31	Current assets / current liabilities	Not reported	Current Liabilities: 4000 Open source
20102010-12-31	Current assets / current liabilities	1.42×	Current Assets: 505148 Open source Current Liabilities: 356925 Open source
2011-02-28	Current assets / current liabilities	Not reported	No source recorded
20112011-12-31	Current assets / current liabilities	9.51×	Current Assets: 2795315 Open source Current Liabilities: 293794 Open source
20122012-12-31	Current assets / current liabilities	0.99×	Current Assets: 1282375 Open source Current Liabilities: 1300942 Open source
20132013-12-31	Current assets / current liabilities	0.07×	Current Assets: 221530 Open source Current Liabilities: 3299107 Open source
20142014-12-31	Current assets / current liabilities	0.69×	Current Assets: 721743 Open source Current Liabilities: 1044163 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2009-01-01 – 2009-12-31	−USD 755,731 Exact value Exact value: -755731 USD 2009-01-01 – 2009-12-31: -755731 USD Inspect Net Income Open source Share or cite Citation for Net Income · Q Therapeutics, Inc. · 2009-12-31 Q Therapeutics, Inc. (edgar:1366541) Net Income: -755731 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -755731 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312514144283/qhoi-20131231.xml#148123 Filing: 000119312514144283 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2010 2009-06-01 – 2010-05-31	−USD 18,200 Exact value Exact value: -18200 USD 2009-06-01 – 2010-05-31: -18200 USD Inspect Net Income Open source Share or cite Citation for Net Income · Q Therapeutics, Inc. · 2010-05-31 Q Therapeutics, Inc. (edgar:1366541) Net Income: -18200 USD Concept: fundies:NetIncome Period: 2009-06-01 to 2010-05-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3ANetIncome&period=2010-05-31&surface=latest&period_type=duration&start=2009-06-01&unit=USD&dimensions= Input fundies:NetIncome: -18200 USD (2009-06-01 to 2010-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000150441211000118/g2i-20110531.xml#23487 Filing: 000150441211000118 The citation records this snapshot. The page link may show a newer release later.	−USD 8,975 Exact value Exact value: -8975 USD 2009-06-01 – 2010-05-31: -8975 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Q Therapeutics, Inc. · 2010-05-31 Q Therapeutics, Inc. (edgar:1366541) Operating Cash Flow: -8975 USD Concept: fundies:OperatingCashFlow Period: 2009-06-01 to 2010-05-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3AOperatingCashFlow&period=2010-05-31&surface=latest&period_type=duration&start=2009-06-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8975 USD (2009-06-01 to 2010-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000150441211000118/g2i-20110531.xml#23036 Filing: 000150441211000118 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2009-12-01 – 2010-11-30	−USD 18,200 Exact value Exact value: -18200 USD 2009-12-01 – 2010-11-30: -18200 USD Inspect Net Income Open source Share or cite Citation for Net Income · Q Therapeutics, Inc. · 2010-11-30 Q Therapeutics, Inc. (edgar:1366541) Net Income: -18200 USD Concept: fundies:NetIncome Period: 2009-12-01 to 2010-11-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3ANetIncome&period=2010-11-30&surface=latest&period_type=duration&start=2009-12-01&unit=USD&dimensions= Input fundies:NetIncome: -18200 USD (2009-12-01 to 2010-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/0001144204-11-040468.txt#2461 The citation records this snapshot. The page link may show a newer release later.	−USD 8,975 Exact value Exact value: -8975 USD 2009-12-01 – 2010-11-30: -8975 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Q Therapeutics, Inc. · 2010-11-30 Q Therapeutics, Inc. (edgar:1366541) Operating Cash Flow: -8975 USD Concept: fundies:OperatingCashFlow Period: 2009-12-01 to 2010-11-30 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3AOperatingCashFlow&period=2010-11-30&surface=latest&period_type=duration&start=2009-12-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8975 USD (2009-12-01 to 2010-11-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/0001144204-11-040468.txt#2679 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	−USD 864,850 Exact value Exact value: -864850 USD 2010-01-01 – 2010-12-31: -864850 USD Inspect Net Income Open source Share or cite Citation for Net Income · Q Therapeutics, Inc. · 2010-12-31 Q Therapeutics, Inc. (edgar:1366541) Net Income: -864850 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -864850 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312514144283/qhoi-20131231.xml#150143 Filing: 000119312514144283 The citation records this snapshot. The page link may show a newer release later.	−USD 811,794 Exact value Exact value: -811794 USD 2010-01-01 – 2010-12-31: -811794 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Q Therapeutics, Inc. · 2010-12-31 Q Therapeutics, Inc. (edgar:1366541) Operating Cash Flow: -811794 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -811794 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000138713112000814/q-20111231.xml#64236 Filing: 000138713112000814 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2011 2010-03-01 – 2011-02-28	−USD 18,200 Exact value Exact value: -18200 USD 2010-03-01 – 2011-02-28: -18200 USD Inspect Net Income Open source Share or cite Citation for Net Income · Q Therapeutics, Inc. · 2011-02-28 Q Therapeutics, Inc. (edgar:1366541) Net Income: -18200 USD Concept: fundies:NetIncome Period: 2010-03-01 to 2011-02-28 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3ANetIncome&period=2011-02-28&surface=latest&period_type=duration&start=2010-03-01&unit=USD&dimensions= Input fundies:NetIncome: -18200 USD (2010-03-01 to 2011-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/0001144204-11-040470.txt#2568 The citation records this snapshot. The page link may show a newer release later.	−USD 8,975 Exact value Exact value: -8975 USD 2010-03-01 – 2011-02-28: -8975 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Q Therapeutics, Inc. · 2011-02-28 Q Therapeutics, Inc. (edgar:1366541) Operating Cash Flow: -8975 USD Concept: fundies:OperatingCashFlow Period: 2010-03-01 to 2011-02-28 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3AOperatingCashFlow&period=2011-02-28&surface=latest&period_type=duration&start=2010-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8975 USD (2010-03-01 to 2011-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/0001144204-11-040470.txt#2760 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2011 2010-06-01 – 2011-05-31	−USD 83,650 Exact value Exact value: -83650 USD 2010-06-01 – 2011-05-31: -83650 USD Inspect Net Income Open source Share or cite Citation for Net Income · Q Therapeutics, Inc. · 2011-05-31 Q Therapeutics, Inc. (edgar:1366541) Net Income: -83650 USD Concept: fundies:NetIncome Period: 2010-06-01 to 2011-05-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3ANetIncome&period=2011-05-31&surface=latest&period_type=duration&start=2010-06-01&unit=USD&dimensions= Input fundies:NetIncome: -83650 USD (2010-06-01 to 2011-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000150441211000118/g2i-20110531.xml#23599 Filing: 000150441211000118 The citation records this snapshot. The page link may show a newer release later.	−USD 9,375 Exact value Exact value: -9375 USD 2010-06-01 – 2011-05-31: -9375 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Q Therapeutics, Inc. · 2011-05-31 Q Therapeutics, Inc. (edgar:1366541) Operating Cash Flow: -9375 USD Concept: fundies:OperatingCashFlow Period: 2010-06-01 to 2011-05-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3AOperatingCashFlow&period=2011-05-31&surface=latest&period_type=duration&start=2010-06-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9375 USD (2010-06-01 to 2011-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000150441211000118/g2i-20110531.xml#23205 Filing: 000150441211000118 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2011 2011-01-01 – 2011-12-31	−USD 2.6 million Exact value Exact value: -2599338 USD 2011-01-01 – 2011-12-31: -2599338 USD Inspect Net Income Open source Share or cite Citation for Net Income · Q Therapeutics, Inc. · 2011-12-31 Q Therapeutics, Inc. (edgar:1366541) Net Income: -2599338 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2599338 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312514144283/qhoi-20131231.xml#157873 Filing: 000119312514144283 The citation records this snapshot. The page link may show a newer release later.	−USD 1.67 million Exact value Exact value: -1665370 USD 2011-01-01 – 2011-12-31: -1665370 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Q Therapeutics, Inc. · 2011-12-31 Q Therapeutics, Inc. (edgar:1366541) Operating Cash Flow: -1665370 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1665370 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312513265928/qhoi-20130331.xml#175194 Filing: 000119312513265928 The citation records this snapshot. The page link may show a newer release later.	USD 5,627 Exact value Exact value: 5627 USD 2011-01-01 – 2011-12-31: 5627 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Q Therapeutics, Inc. · 2011-12-31 Q Therapeutics, Inc. (edgar:1366541) Capital Expenditure: 5627 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5627 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312513265928/qhoi-20130331.xml#175367 Filing: 000119312513265928 The citation records this snapshot. The page link may show a newer release later.	−USD 1.67 million Calculation and evidence -1665370 − 5627 USD Exact free cash flow: -1670997 USD 2011-01-01 – 2011-12-31: -1665370 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 5627 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Q Therapeutics, Inc. · 2011-12-31 Q Therapeutics, Inc. (edgar:1366541) Free cash flow: -1670997 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1665370 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312513265928/qhoi-20130331.xml#175194 Filing: 000119312513265928 Input fundies:CapitalExpenditure: 5627 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312513265928/qhoi-20130331.xml#175367 Filing: 000119312513265928 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 3.06 million Exact value Exact value: -3057840 USD 2012-01-01 – 2012-12-31: -3057840 USD Inspect Net Income Open source Share or cite Citation for Net Income · Q Therapeutics, Inc. · 2012-12-31 Q Therapeutics, Inc. (edgar:1366541) Net Income: -3057840 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3057840 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312514144283/qhoi-20131231.xml#120128 Filing: 000119312514144283 The citation records this snapshot. The page link may show a newer release later.	−USD 2.12 million Exact value Exact value: -2121749 USD 2012-01-01 – 2012-12-31: -2121749 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Q Therapeutics, Inc. · 2012-12-31 Q Therapeutics, Inc. (edgar:1366541) Operating Cash Flow: -2121749 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2121749 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312514144283/qhoi-20131231.xml#126728 Filing: 000119312514144283 The citation records this snapshot. The page link may show a newer release later.	USD 2,363 Exact value Exact value: 2363 USD 2012-01-01 – 2012-12-31: 2363 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Q Therapeutics, Inc. · 2012-12-31 Q Therapeutics, Inc. (edgar:1366541) Capital Expenditure: 2363 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2363 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312514144283/qhoi-20131231.xml#126901 Filing: 000119312514144283 The citation records this snapshot. The page link may show a newer release later.	−USD 2.12 million Calculation and evidence -2121749 − 2363 USD Exact free cash flow: -2124112 USD 2012-01-01 – 2012-12-31: -2121749 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 2363 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Q Therapeutics, Inc. · 2012-12-31 Q Therapeutics, Inc. (edgar:1366541) Free cash flow: -2124112 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2121749 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312514144283/qhoi-20131231.xml#126728 Filing: 000119312514144283 Input fundies:CapitalExpenditure: 2363 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312514144283/qhoi-20131231.xml#126901 Filing: 000119312514144283 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 3.39 million Exact value Exact value: -3389092 USD 2013-01-01 – 2013-12-31: -3389092 USD Inspect Net Income Open source Share or cite Citation for Net Income · Q Therapeutics, Inc. · 2013-12-31 Q Therapeutics, Inc. (edgar:1366541) Net Income: -3389092 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3389092 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312515114403/qhoi-20141231.xml#64258 Filing: 000119312515114403 The citation records this snapshot. The page link may show a newer release later.	−USD 877,873 Exact value Exact value: -877873 USD 2013-01-01 – 2013-12-31: -877873 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Q Therapeutics, Inc. · 2013-12-31 Q Therapeutics, Inc. (edgar:1366541) Operating Cash Flow: -877873 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -877873 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312515114403/qhoi-20141231.xml#73766 Filing: 000119312515114403 The citation records this snapshot. The page link may show a newer release later.	USD 23,802 Exact value Exact value: 23802 USD 2013-01-01 – 2013-12-31: 23802 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Q Therapeutics, Inc. · 2013-12-31 Q Therapeutics, Inc. (edgar:1366541) Capital Expenditure: 23802 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 23802 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312515114403/qhoi-20141231.xml#73938 Filing: 000119312515114403 The citation records this snapshot. The page link may show a newer release later.	−USD 901,675 Calculation and evidence -877873 − 23802 USD Exact free cash flow: -901675 USD 2013-01-01 – 2013-12-31: -877873 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 23802 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Q Therapeutics, Inc. · 2013-12-31 Q Therapeutics, Inc. (edgar:1366541) Free cash flow: -901675 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -877873 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312515114403/qhoi-20141231.xml#73766 Filing: 000119312515114403 Input fundies:CapitalExpenditure: 23802 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312515114403/qhoi-20141231.xml#73938 Filing: 000119312515114403 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 3.35 million Exact value Exact value: -3350701 USD 2014-01-01 – 2014-12-31: -3350701 USD Inspect Net Income Open source Share or cite Citation for Net Income · Q Therapeutics, Inc. · 2014-12-31 Q Therapeutics, Inc. (edgar:1366541) Net Income: -3350701 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3350701 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312515114403/qhoi-20141231.xml#61896 Filing: 000119312515114403 The citation records this snapshot. The page link may show a newer release later.	−USD 1.46 million Exact value Exact value: -1458653 USD 2014-01-01 – 2014-12-31: -1458653 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Q Therapeutics, Inc. · 2014-12-31 Q Therapeutics, Inc. (edgar:1366541) Operating Cash Flow: -1458653 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1458653 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312515114403/qhoi-20141231.xml#71538 Filing: 000119312515114403 The citation records this snapshot. The page link may show a newer release later.	USD 8,234 Exact value Exact value: 8234 USD 2014-01-01 – 2014-12-31: 8234 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Q Therapeutics, Inc. · 2014-12-31 Q Therapeutics, Inc. (edgar:1366541) Capital Expenditure: 8234 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8234 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312515114403/qhoi-20141231.xml#71711 Filing: 000119312515114403 The citation records this snapshot. The page link may show a newer release later.	−USD 1.47 million Calculation and evidence -1458653 − 8234 USD Exact free cash flow: -1466887 USD 2014-01-01 – 2014-12-31: -1458653 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 8234 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Q Therapeutics, Inc. · 2014-12-31 Q Therapeutics, Inc. (edgar:1366541) Free cash flow: -1466887 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1366541?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1458653 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312515114403/qhoi-20141231.xml#71538 Filing: 000119312515114403 Input fundies:CapitalExpenditure: 8234 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1366541/000119312515114403/qhoi-20141231.xml#71711 Filing: 000119312515114403 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

42 filings · 1,363 latest values · 1,363 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001366541, 1366541, edgar:1366541

Also known as Grace 2, Inc., Q Holdings, Inc., Q Therapeutics, Inc., grace 2, Inc.

Q Therapeutics, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2014 2014-01-01 – 2014-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation